Cytodyn Inc (CYDY)

[misiu143]

This might be true about lenzilumab..
Lenzilumab is an GM-CSF inhibitor .

And when dr Patterson was still with CYDY , he saw tests of hundreds of COVID patients , and his observation was that only about 20-30% of the patients with COVD showing elevated GM-CSF , and many not even that much .

So if it is true , how lenzilumab could work in many..

And inhibition of GM-CSF could produce immunosuppression , this is why during their study they picked very carefully all the patients , any patient with any secondary , viral , bacterial or fungi infection was excluded.
And this is possibly why FDA saying that risk must be evaluated more carefully in their treatment.

In contrary leronlimab is down regulating GM-CSF but not inhibiting completely to produce immunosuppression.

I like very fast enrollment in Brazil with leronlimab , and our results finally , officially showing why our patients in EIND and RTT , coming off the ventilators and ECMO and going home.

All IMO.